Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

185 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Testosterone and prostate cancer: what are the risks for middle-aged men?
Morgentaler A. Morgentaler A. Urol Clin North Am. 2011 May;38(2):119-24. doi: 10.1016/j.ucl.2011.02.002. Epub 2011 Apr 13. Urol Clin North Am. 2011. PMID: 21621078 Review.
Occult prostate cancer in men with low serum testosterone levels.
Morgentaler A, Bruning CO 3rd, DeWolf WC. Morgentaler A, et al. JAMA. 1996 Dec 18;276(23):1904-6. JAMA. 1996. PMID: 8968017
Is low serum free testosterone a marker for high grade prostate cancer?
Hoffman MA, DeWolf WC, Morgentaler A. Hoffman MA, et al. Among authors: morgentaler a. J Urol. 2000 Mar;163(3):824-7. J Urol. 2000. PMID: 10687985
The value of pituitary magnetic resonance imaging in men with hypogonadism.
Rhoden EL, Estrada C, Levine L, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. J Urol. 2003 Sep;170(3):795-8. doi: 10.1097/01.ju.0000082960.84075.54. J Urol. 2003. PMID: 12913700
Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. J Urol. 2003 Dec;170(6 Pt 1):2348-51. doi: 10.1097/01.ju.0000091104.71869.8e. J Urol. 2003. PMID: 14634413
Risks of testosterone-replacement therapy and recommendations for monitoring.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. N Engl J Med. 2004 Jan 29;350(5):482-92. doi: 10.1056/NEJMra022251. N Engl J Med. 2004. PMID: 14749457 Review. No abstract available.
Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. Int J Impot Res. 2004 Feb;16(1):95-7. doi: 10.1038/sj.ijir.3901154. Int J Impot Res. 2004. PMID: 14963480
A 66-year-old man with sexual dysfunction.
Morgentaler A. Morgentaler A. JAMA. 2004 Jun 23;291(24):2994-3003. doi: 10.1001/jama.291.24.2994. JAMA. 2004. PMID: 15213212 No abstract available.
Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. Int J Impot Res. 2006 Mar-Apr;18(2):201-5. doi: 10.1038/sj.ijir.3901394. Int J Impot Res. 2006. PMID: 16177827
Hypogonadism in the man with erectile dysfunction: what to look for and when to treat.
Lazarou S, Morgentaler A. Lazarou S, et al. Among authors: morgentaler a. Curr Urol Rep. 2005 Nov;6(6):476-81. doi: 10.1007/s11934-005-0044-z. Curr Urol Rep. 2005. PMID: 16238923 Review.
185 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback